Lesions outside the CNS in Parkinson's disease
Identifieur interne : 000424 ( Main/Corpus ); précédent : 000423; suivant : 000425Lesions outside the CNS in Parkinson's disease
Auteurs : Ruth Djaldetti ; Nirit Lev ; Eldad MelamedSource :
- Movement Disorders [ 0885-3185 ] ; 2009-04-30.
English descriptors
Abstract
Parkinson's disease (PD) is not a simple movement disorder induced just by loss of dopaminergic neurons in the substantia nigra pars compacta. Apparently, the substantia nigra is not the only or the first brain region damaged in PD. Moreover, older and recent studies have shown that the degenerative process in PD is much more extensive and affects not only the central nervous system (CNS) but also the peripheral autonomic nervous system and the organs outside the brain that the latter innervates. These include mainly the gastrointestinal tract, the heart, kidneys, urogenital system, and skin. Additional extra‐CNS organs that are involved in PD include the eye and the adrenal gland. This article reviews the anatomical, physiological, and clinical features of extracerebral manifestations of PD, and describes their relevance to the etiology and pathogenesis of the disease. It establishes this illness as a systemic CNS and peripheral disorder that warrants new hypotheses regarding its causation and progression. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22172
Links to Exploration step
ISTEX:3120025AA46CBF0D40AFA45223C87E088F633253Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lesions outside the CNS in Parkinson's disease</title><author><name sortKey="Djaldetti, Ruth" sort="Djaldetti, Ruth" uniqKey="Djaldetti R" first="Ruth" last="Djaldetti">Ruth Djaldetti</name><affiliation><mods:affiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</mods:affiliation></affiliation><affiliation><mods:affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</mods:affiliation></affiliation></author><author><name sortKey="Lev, Nirit" sort="Lev, Nirit" uniqKey="Lev N" first="Nirit" last="Lev">Nirit Lev</name><affiliation><mods:affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</mods:affiliation></affiliation><affiliation><mods:affiliation>Felsenstein Research Center, Beilinson Campus, Petah Tiqva, Israel</mods:affiliation></affiliation></author><author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name><affiliation><mods:affiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</mods:affiliation></affiliation><affiliation><mods:affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3120025AA46CBF0D40AFA45223C87E088F633253</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22172</idno><idno type="url">https://api.istex.fr/document/3120025AA46CBF0D40AFA45223C87E088F633253/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000424</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Lesions outside the CNS in Parkinson's disease</title><author><name sortKey="Djaldetti, Ruth" sort="Djaldetti, Ruth" uniqKey="Djaldetti R" first="Ruth" last="Djaldetti">Ruth Djaldetti</name><affiliation><mods:affiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</mods:affiliation></affiliation><affiliation><mods:affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</mods:affiliation></affiliation></author><author><name sortKey="Lev, Nirit" sort="Lev, Nirit" uniqKey="Lev N" first="Nirit" last="Lev">Nirit Lev</name><affiliation><mods:affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</mods:affiliation></affiliation><affiliation><mods:affiliation>Felsenstein Research Center, Beilinson Campus, Petah Tiqva, Israel</mods:affiliation></affiliation></author><author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name><affiliation><mods:affiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</mods:affiliation></affiliation><affiliation><mods:affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-04-30">2009-04-30</date><biblScope unit="volume">24</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="793">793</biblScope><biblScope unit="page" to="800">800</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">3120025AA46CBF0D40AFA45223C87E088F633253</idno><idno type="DOI">10.1002/mds.22172</idno><idno type="ArticleID">MDS22172</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson disease</term><term>autonomic system</term><term>peripheral organs</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is not a simple movement disorder induced just by loss of dopaminergic neurons in the substantia nigra pars compacta. Apparently, the substantia nigra is not the only or the first brain region damaged in PD. Moreover, older and recent studies have shown that the degenerative process in PD is much more extensive and affects not only the central nervous system (CNS) but also the peripheral autonomic nervous system and the organs outside the brain that the latter innervates. These include mainly the gastrointestinal tract, the heart, kidneys, urogenital system, and skin. Additional extra‐CNS organs that are involved in PD include the eye and the adrenal gland. This article reviews the anatomical, physiological, and clinical features of extracerebral manifestations of PD, and describes their relevance to the etiology and pathogenesis of the disease. It establishes this illness as a systemic CNS and peripheral disorder that warrants new hypotheses regarding its causation and progression. © 2009 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Ruth Djaldetti MD</name><affiliations><json:string>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</json:string><json:string>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</json:string></affiliations></json:item><json:item><name>Nirit Lev MD</name><affiliations><json:string>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</json:string><json:string>Felsenstein Research Center, Beilinson Campus, Petah Tiqva, Israel</json:string></affiliations></json:item><json:item><name>Eldad Melamed MD</name><affiliations><json:string>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</json:string><json:string>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>autonomic system</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>peripheral organs</value></json:item></subject><articleId><json:string>MDS22172</json:string></articleId><language><json:string>eng</json:string></language><abstract>Parkinson's disease (PD) is not a simple movement disorder induced just by loss of dopaminergic neurons in the substantia nigra pars compacta. Apparently, the substantia nigra is not the only or the first brain region damaged in PD. Moreover, older and recent studies have shown that the degenerative process in PD is much more extensive and affects not only the central nervous system (CNS) but also the peripheral autonomic nervous system and the organs outside the brain that the latter innervates. These include mainly the gastrointestinal tract, the heart, kidneys, urogenital system, and skin. Additional extra‐CNS organs that are involved in PD include the eye and the adrenal gland. This article reviews the anatomical, physiological, and clinical features of extracerebral manifestations of PD, and describes their relevance to the etiology and pathogenesis of the disease. It establishes this illness as a systemic CNS and peripheral disorder that warrants new hypotheses regarding its causation and progression. © 2009 Movement Disorder Society</abstract><qualityIndicators><score>6.92</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 810 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>3</keywordCount><abstractCharCount>1055</abstractCharCount><pdfWordCount>5624</pdfWordCount><pdfCharCount>37838</pdfCharCount><pdfPageCount>8</pdfPageCount><abstractWordCount>160</abstractWordCount></qualityIndicators><title>Lesions outside the CNS in Parkinson's disease</title><genre><json:string>review-article</json:string></genre><host><volume>24</volume><publisherId><json:string>MDS</json:string></publisherId><pages><total>8</total><last>800</last><first>793</first></pages><issn><json:string>0885-3185</json:string></issn><issue>6</issue><subject><json:item><value>Review</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8257</json:string></eissn><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2009</publicationDate><copyrightDate>2009</copyrightDate><doi><json:string>10.1002/mds.22172</json:string></doi><id>3120025AA46CBF0D40AFA45223C87E088F633253</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/3120025AA46CBF0D40AFA45223C87E088F633253/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/3120025AA46CBF0D40AFA45223C87E088F633253/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/3120025AA46CBF0D40AFA45223C87E088F633253/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Lesions outside the CNS in Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2009</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Lesions outside the CNS in Parkinson's disease</title><author><persName><forename type="first">Ruth</forename><surname>Djaldetti</surname></persName><roleName type="degree">MD</roleName><note type="correspondence"><p>Correspondence: Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49100, Israel</p></note><affiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</affiliation><affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</affiliation></author><author><persName><forename type="first">Nirit</forename><surname>Lev</surname></persName><roleName type="degree">MD</roleName><affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</affiliation><affiliation>Felsenstein Research Center, Beilinson Campus, Petah Tiqva, Israel</affiliation></author><author><persName><forename type="first">Eldad</forename><surname>Melamed</surname></persName><roleName type="degree">MD</roleName><affiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</affiliation><affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-04-30"></date><biblScope unit="volume">24</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="793">793</biblScope><biblScope unit="page" to="800">800</biblScope></imprint></monogr><idno type="istex">3120025AA46CBF0D40AFA45223C87E088F633253</idno><idno type="DOI">10.1002/mds.22172</idno><idno type="ArticleID">MDS22172</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2009</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Parkinson's disease (PD) is not a simple movement disorder induced just by loss of dopaminergic neurons in the substantia nigra pars compacta. Apparently, the substantia nigra is not the only or the first brain region damaged in PD. Moreover, older and recent studies have shown that the degenerative process in PD is much more extensive and affects not only the central nervous system (CNS) but also the peripheral autonomic nervous system and the organs outside the brain that the latter innervates. These include mainly the gastrointestinal tract, the heart, kidneys, urogenital system, and skin. Additional extra‐CNS organs that are involved in PD include the eye and the adrenal gland. This article reviews the anatomical, physiological, and clinical features of extracerebral manifestations of PD, and describes their relevance to the etiology and pathogenesis of the disease. It establishes this illness as a systemic CNS and peripheral disorder that warrants new hypotheses regarding its causation and progression. © 2009 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson disease</term></item><item><term>autonomic system</term></item><item><term>peripheral organs</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Review</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2008-04-17">Received</change><change when="2008-05-10">Registration</change><change when="2009-04-30">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/3120025AA46CBF0D40AFA45223C87E088F633253/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="60"><doi origin="wiley" registered="yes">10.1002/mds.v24:6</doi><numberingGroup><numbering type="journalVolume" number="24">24</numbering><numbering type="journalIssue">6</numbering></numberingGroup><coverDate startDate="2009-04-30">30 April 2009</coverDate></publicationMeta><publicationMeta level="unit" type="reviewArticle" position="10" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.22172</doi><idGroup><id type="unit" value="MDS22172"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="articleCategory">Review</title><title type="tocHeading1">Reviews</title></titleGroup><copyright ownership="thirdParty">Copyright © 2009 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2008-04-17"></event><event type="manuscriptRevised" date="2008-05-07"></event><event type="manuscriptAccepted" date="2008-05-10"></event><event type="publishedOnlineEarlyUnpaginated" date="2009-02-17"></event><event type="firstOnline" date="2009-02-17"></event><event type="publishedOnlineFinalForm" date="2009-04-24"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.6 mode:FullText source:FullText result:FullText" date="2010-04-20"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">793</numbering><numbering type="pageLast">800</numbering></numberingGroup><correspondenceTo>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49100, Israel</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS22172.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="117"></count><count type="wordTotal" number="5419"></count></countGroup><titleGroup><title type="main" xml:lang="en">Lesions outside the CNS in Parkinson's disease</title><title type="short" xml:lang="en">Lesions outside the CNS in PD</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af2" corresponding="yes"><personName><givenNames>Ruth</givenNames><familyName>Djaldetti</familyName><degrees>MD</degrees></personName><contactDetails><email>ruthdjal@clalit.org.il</email></contactDetails></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2 #af3"><personName><givenNames>Nirit</givenNames><familyName>Lev</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Eldad</givenNames><familyName>Melamed</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="IL" type="organization"><unparsedAffiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="IL" type="organization"><unparsedAffiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="IL" type="organization"><unparsedAffiliation>Felsenstein Research Center, Beilinson Campus, Petah Tiqva, Israel</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson disease</keyword><keyword xml:id="kwd2">autonomic system</keyword><keyword xml:id="kwd3">peripheral organs</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Parkinson's disease (PD) is not a simple movement disorder induced just by loss of dopaminergic neurons in the substantia nigra pars compacta. Apparently, the substantia nigra is not the only or the first brain region damaged in PD. Moreover, older and recent studies have shown that the degenerative process in PD is much more extensive and affects not only the central nervous system (CNS) but also the peripheral autonomic nervous system and the organs outside the brain that the latter innervates. These include mainly the gastrointestinal tract, the heart, kidneys, urogenital system, and skin. Additional extra‐CNS organs that are involved in PD include the eye and the adrenal gland. This article reviews the anatomical, physiological, and clinical features of extracerebral manifestations of PD, and describes their relevance to the etiology and pathogenesis of the disease. It establishes this illness as a systemic CNS and peripheral disorder that warrants new hypotheses regarding its causation and progression. © 2009 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Lesions outside the CNS in Parkinson's disease</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Lesions outside the CNS in PD</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Lesions outside the CNS in Parkinson's disease</title></titleInfo><name type="personal"><namePart type="given">Ruth</namePart><namePart type="family">Djaldetti</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</affiliation><affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</affiliation><description>Correspondence: Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49100, Israel</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Nirit</namePart><namePart type="family">Lev</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</affiliation><affiliation>Felsenstein Research Center, Beilinson Campus, Petah Tiqva, Israel</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Eldad</namePart><namePart type="family">Melamed</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel</affiliation><affiliation>The Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2009-04-30</dateIssued><dateCaptured encoding="w3cdtf">2008-04-17</dateCaptured><dateValid encoding="w3cdtf">2008-05-10</dateValid><copyrightDate encoding="w3cdtf">2009</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">117</extent><extent unit="words">5419</extent></physicalDescription><abstract lang="en">Parkinson's disease (PD) is not a simple movement disorder induced just by loss of dopaminergic neurons in the substantia nigra pars compacta. Apparently, the substantia nigra is not the only or the first brain region damaged in PD. Moreover, older and recent studies have shown that the degenerative process in PD is much more extensive and affects not only the central nervous system (CNS) but also the peripheral autonomic nervous system and the organs outside the brain that the latter innervates. These include mainly the gastrointestinal tract, the heart, kidneys, urogenital system, and skin. Additional extra‐CNS organs that are involved in PD include the eye and the adrenal gland. This article reviews the anatomical, physiological, and clinical features of extracerebral manifestations of PD, and describes their relevance to the etiology and pathogenesis of the disease. It establishes this illness as a systemic CNS and peripheral disorder that warrants new hypotheses regarding its causation and progression. © 2009 Movement Disorder Society</abstract><subject lang="en"><genre>Keywords</genre><topic>Parkinson disease</topic><topic>autonomic system</topic><topic>peripheral organs</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Review</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><detail type="issue"><caption>no.</caption><number>6</number></detail><extent unit="pages"><start>793</start><end>800</end><total>8</total></extent></part></relatedItem><identifier type="istex">3120025AA46CBF0D40AFA45223C87E088F633253</identifier><identifier type="DOI">10.1002/mds.22172</identifier><identifier type="ArticleID">MDS22172</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2009 Movement Disorder Society</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000424 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000424 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:3120025AA46CBF0D40AFA45223C87E088F633253
|texte= Lesions outside the CNS in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |